Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Hofer Eva-Maria |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2017
Originalarbeit (Zeitschrift)
** Kessler, SM; Lederer, E; Laggai, S; Golob-Schwarzl, N; Hosseini, K; Petzold, J; Schweiger, C; Reihs, R; Keil, M; Hoffmann, J; Mayr, C; Kiesslich, T; Pichler, M; Kim, KS; Rhee, H; Park, YN; Lax, S; Obrist, P; Kiemer, AK; Haybaeck, J
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
Oncotarget. 2017; 8(52):89736-89745
Doi: 10.18632/oncotarget.21116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Kessler, SM; Laggai, S; Barghash, A; Schultheiss, CS; Lederer, E; Artl, M; Helms, V; Haybaeck, J; Kiemer, AK
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.
Cell Death Dis. 2015; 6(1):e1894-e1894
Doi: 10.1038/cddis.2015.241
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40.
[Oral Communication]
Web of Science
** Lederer, E; Petzold, J; Rehis, R; Ernst, C; Bettermann, K; Golob-Schwarzl, N; Moriggl, R; Schlederer, M; Lax, S; Hoffmann, J; Haybaek, J
The role of the JAK/STAT pathway in gallbladder cancer
VIRCHOWS ARCH. 2015; 467: S3-S3.
[Oral Communication]
Web of Science
2014
Originalarbeit (Zeitschrift)
** Laggai, S; Kessler, SM; Boettcher, S; Lebrun, V; Gemperlein, K; Lederer, E; Leclercq, IA; Mueller, R; Hartmann, RW; Haybaeck, J; Kiemer, AK
The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.
J Lipid Res. 2014; 55(6):1087-1097
Doi: 10.1194/jlr.M045500
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spilka, R; Ernst, C; Bergler, H; Rainer, J; Flechsig, S; Vogetseder, A; Lederer, E; Benesch, M; Brunner, A; Geley, S; Eger, A; Bachmann, F; Doppler, W; Obrist, P; Haybaeck, J
eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.
Cell Oncol (Dordr). 2014; 37(4):253-267
Doi: 10.1007/s13402-014-0181-9
Web of Science
PubMed
FullText
FullText_MUG
2013
Abstract (Zeitschrift)
** Bettermann, K; Mehta, AK; Lederer, E; Ernst, C; Kessler, SM; Chen, X; Hoshida, Y; Bardeesy, N; Fuchs, BC; Tanabe, KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Mahajan, V; Stumptner, C; Thueringer, A; Stojakovic, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Moriggl, R; Campbell, JS; Thorgeirsson, SS; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Lackner, C; Haybäck, J
Steatohepatitis-associated Hepatocellular Carcinoma: Evidence of a Keratinopathy.
HEPATOLOGY. 2013; 58(S1):543A-543A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA.
[Poster]
Web of Science
** Kessler, SM; Lederer, E; Reihs, R; Kiemer, AK; Hayback, J
Overexpression of the insulin-like growth factor 2 (IGF2) mRNA binding protein (IMP) p62 as a marker of poor outcome in gallbladder cancer
HEPATOLOGY. 2013; 58: 1079A-1079A.-64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases; NOV 01-05, 2013; Washington, DC.
[Poster]
Web of Science
2012
Abstract (Zeitschrift)
** Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Hayback, J; Denk, H; Lackner, C
Prognostic relevance of Mallory-Denk and intracytoplasmic hyaline bodies in hepatocellular carcinoma
HEPATOLOGY. 2012; 56: 474A-475A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
** Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Haybaeck, J; Denk, H; Lackner, C
PROGNOSTIC RELEVANCE OF MALLORY-DENK BODIES AND INTRACELLULAR HYALINE BODIES IN HEPATOCELLULAR CARCINOMA
J HEPATOL. 2012; 56: S287-S287.
Doi: 10.1016/S0168-8278(12)60741-7
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Bettermann, K; Mehta, AK; Lederer, E; Diwoky, C; Thuringer, A; Muller, H; Mahajan, VS; Stumptner, C; Kolbe, T; Magin, TM; Denk, H; Lackner, C; Zatloukal, K; Haybaeck, J;
Steatohepatitis-driven hepatocellular carcinoma.
INT J MOL MED. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE30: S6-S6. ATHENS: SPANDIDOS PUBL LTD;
[Oral Communication]
Web of Science
** Quan, P; Lederer, E; Halbwedl, I; Denk, H; Zatloukal, K; Haybaeck, J;
Targeting endometrial stromal sarcoma: Histone deacetylase and PI3K/Akt/mTOR signaling.
VIRCHOWS ARCHIV. VIRCHOWS ARCHIV461: S31-S31. NEW YORK: SPRINGER;
[Oral Communication]
Web of Science